Literature DB >> 6628629

Early adrenalectomy stimulates subsequent growth and development of the rat brain.

J S Meyer.   

Abstract

Rats were adrenalectomized (ADX) or sham-operated (SHAM) on the 11th day of life and subsequent brain development (cerebrum and cerebellum) studied in terms of tissue weight and biochemical composition. Measured at about 65 days of age, early ADX subjects had significantly heavier brains (in terms of both wet and dry weights) than SHAMs, despite being lighter in overall body weight. Brain protein and DNA contents were elevated, as was the activity of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), a myelin marker enzyme. Glycerol-3-phosphate dehydrogenase (GPDH), a glucocorticoid-regulated enzyme, was reduced in activity. Although both the cerebrum and cerebellum showed the growth-enhancing effects of early adrenalectomy, the DNA and CNP changes were most pronounced in the cerebrum. Finally, the effect of adrenal removal on myelinogenesis was confirmed by subcellular fractionation experiments demonstrating that more myelin could be recovered from the brains of ADX than from SHAM animals. These results are significant in terms of the influence of adrenal secretions on normal brain development and the role of GPDH in myelin lipid biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628629     DOI: 10.1016/0014-4886(83)90415-6

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  38 in total

1.  Severe early life stress hampers spatial learning and neurogenesis, but improves hippocampal synaptic plasticity and emotional learning under high-stress conditions in adulthood.

Authors:  Charlotte A Oomen; Heleen Soeters; Nathalie Audureau; Lisa Vermunt; Felisa N van Hasselt; Erik M M Manders; Marian Joëls; Paul J Lucassen; Harm Krugers
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

2.  Pubertal ovarian hormone exposure reduces the number of myelinated axons in the splenium of the rat corpus callosum.

Authors:  M A Yates; J M Juraska
Journal:  Exp Neurol       Date:  2007-10-25       Impact factor: 5.330

Review 3.  Glucocorticoids and the hippocampus. Developmental interactions facilitating the expression of behavioral inhibition.

Authors:  L K Takahashi
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

4.  Immunohistochemical study on the development of the adenohypophysial cells in the lizard Gallotia galloti.

Authors:  M A Batista; J Doerr-Schott; A R Bello
Journal:  Anat Embryol (Berl)       Date:  1989

5.  Prenatal maternal cortisol concentrations predict neurodevelopment in middle childhood.

Authors:  Elysia Poggi Davis; Kevin Head; Claudia Buss; Curt A Sandman
Journal:  Psychoneuroendocrinology       Date:  2016-10-15       Impact factor: 4.905

Review 6.  Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression.

Authors:  Linda Booij; Dongsha Wang; Mélissa L Lévesque; Richard E Tremblay; Moshe Szyf
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

7.  Child physical abuse and adult mental health: a national study.

Authors:  Luisa Sugaya; Deborah S Hasin; Mark Olfson; Keng-Han Lin; Bridget F Grant; Carlos Blanco
Journal:  J Trauma Stress       Date:  2012-07-16

Review 8.  Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions.

Authors:  Yong Li; Pablo Gonzalez; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2012-05-22       Impact factor: 11.685

9.  Lithium protects against glucocorticoid induced neural progenitor cell apoptosis in the developing cerebellum.

Authors:  Omar Cabrera; Joseph Dougherty; Sukrit Singh; Brant S Swiney; Nuri B Farber; Kevin K Noguchi
Journal:  Brain Res       Date:  2013-12-19       Impact factor: 3.252

Review 10.  Role of the hypothalamic-pituitary-adrenal axis in developmental programming of health and disease.

Authors:  Fuxia Xiong; Lubo Zhang
Journal:  Front Neuroendocrinol       Date:  2012-11-27       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.